These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37578626)

  • 21. Association between preoperative administration of gabapentinoids and 30-day hospital readmission: A retrospective hospital registry study.
    Wachtendorf LJ; Schaefer MS; Santer P; Azimaraghi O; Obeidat SS; Friedrich S; Zucco L; Woo A; Nabel S; Sundar E; Eikermann M; Ramachandran SK
    J Clin Anesth; 2021 Oct; 73():110376. PubMed ID: 34098392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determining the Toxicological Significance of Pregabalin in Fatalities.
    Elliott SP; Burke T; Smith C
    J Forensic Sci; 2017 Jan; 62(1):169-173. PubMed ID: 27864947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database.
    Chiappini S; Schifano F
    CNS Drugs; 2016 Jul; 30(7):647-54. PubMed ID: 27312320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gabapentinoid misuse, abuse and non-prescribed obtainment in a United States general population sample.
    Evoy KE; Covvey JR; Peckham AM; Reveles KR
    Int J Clin Pharm; 2021 Aug; 43(4):1055-1064. PubMed ID: 33387188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update.
    Evoy KE; Sadrameli S; Contreras J; Covvey JR; Peckham AM; Morrison MD
    Drugs; 2021 Jan; 81(1):125-156. PubMed ID: 33215352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gabapentinoid Dosing and Associated Toxicities in Patients With or Without Concomitant Opioids During Hospitalization.
    Tu TG; Sadeghi S; Atayee R; Lee K
    Am J Hosp Palliat Care; 2022 May; 39(5):530-534. PubMed ID: 34409886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On the risk of dependence on gabapentinoids].
    Bonnet U; Scherbaum N
    Fortschr Neurol Psychiatr; 2018 Feb; 86(2):82-105. PubMed ID: 29179227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics Associated With U.S. Outpatient Opioid Analgesic Prescribing and Gabapentinoid Co-Prescribing.
    St Clair CO; Golub NI; Ma Y; Song J; Winiecki SK; Menschik DL
    Am J Prev Med; 2020 Jan; 58(1):e11-e19. PubMed ID: 31862105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abuse and Misuse of Pregabalin and Gabapentin.
    Evoy KE; Morrison MD; Saklad SR
    Drugs; 2017 Mar; 77(4):403-426. PubMed ID: 28144823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rise of Pregabalin Poisoning and Abuse Cases in Serbia: A Ten-Year Retrospective Study.
    Antunovic M; Vucinic S; Kotur-Stevuljevic J; Krstic K; Jovic-Stosic J; Kilibarda V; Perkovic-Vukcevic N; Djordjevic S
    Int J Gen Med; 2023; 16():1239-1250. PubMed ID: 37065979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-Dependent Association of Gabapentinoids with Pulmonary Complications After Total Hip and Knee Arthroplasties.
    Ohnuma T; Raghunathan K; Moore S; Setoguchi S; Ellis AR; Fuller M; Whittle J; Pyati S; Bryan WE; Pepin MJ; Bartz RR; Haines KL; Krishnamoorthy V
    J Bone Joint Surg Am; 2020 Feb; 102(3):221-229. PubMed ID: 31804238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in opioid and other analgesic prescribing following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis of early outcomes.
    Nielsen S; Picco L; Russell G; Pearce C; Andrew NE; Lubman DI; Bell JS; Buchbinder R; Xia T
    Int J Drug Policy; 2023 Jul; 117():104053. PubMed ID: 37209441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends and correlates of concurrent opioid and benzodiazepine and/or gabapentinoid use among Ontario nursing home residents.
    Hogan DB; Campitelli MA; Bronskill SE; Iaboni A; Barry HE; Hughes CM; Gill SS; Maxwell CJ
    J Am Geriatr Soc; 2023 Aug; 71(8):2462-2475. PubMed ID: 36942992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concurrent Use of Prescription Opioids and Gabapentinoids in Older Adults.
    Chen C; Lo-Ciganic WH; Winterstein AG; Tighe P; Wei YJ
    Am J Prev Med; 2022 Apr; 62(4):519-528. PubMed ID: 34802816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in gabapentinoid prescribing in UK primary care using the Clinical Practice Research Datalink: an observational study.
    Ashworth J; Bajpai R; Muller S; Bailey J; Helliwell T; Harrisson SA; Whittle R; Mallen CD
    Lancet Reg Health Eur; 2023 Apr; 27():100579. PubMed ID: 37069852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of the demographic factors and toxicology related to deaths due to pregabalin in Northern Ireland.
    Huddleston WR; Robert Lyness J; Quinn A
    J Forensic Leg Med; 2024 Jan; 101():102635. PubMed ID: 38100952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative use of gabapentinoids in France. Mismatch between clinical practice and scientific evidence.
    Martinez V; Carles M; Marret E; Beloeil H;
    Anaesth Crit Care Pain Med; 2018 Feb; 37(1):43-47. PubMed ID: 28363848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How addictive are gabapentin and pregabalin? A systematic review.
    Bonnet U; Scherbaum N
    Eur Neuropsychopharmacol; 2017 Dec; 27(12):1185-1215. PubMed ID: 28988943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intentional Drug Overdose Involving Pregabalin and Gabapentin: Findings from the National Self-Harm Registry Ireland, 2007-2015.
    Daly C; Griffin E; Ashcroft DM; Webb RT; Perry IJ; Arensman E
    Clin Drug Investig; 2018 Apr; 38(4):373-380. PubMed ID: 29264838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concomitant drugs with buprenorphine user deaths.
    Mariottini C; Kriikku P; Ojanperä I
    Drug Alcohol Depend; 2021 Jan; 218():108345. PubMed ID: 33127184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.